Invesaro

Stocks Comparison

BrightSpring Health Services vs Chemed: revenue, profit, margins and growth compared

BrightSpring Health Services brought in $12.9B of revenue in fiscal 2025, Chemed $2.5B in fiscal 2025. Revenue changed by +28.2% at BrightSpring Health Services and +4.1% at Chemed on the year before, so BrightSpring Health Services grew faster. BrightSpring Health Services kept 1.5% of its revenue as net profit, Chemed 10.5%. Free cash flow was $394.7M at BrightSpring Health Services and $325.5M at Chemed.

Side by side, latest fiscal year

BTSGUCHE
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$12.9B$2.5B
Revenue growth+28.2%+4.1%
Net income$190.7M$265.2M
Net margin1.5%10.5%
Free cash flow$394.7M$325.5M
Free cash flow margin3.1%12.9%
Earnings per share (diluted)$0.87$18.34
Cash$88.4M$74.5M
Debt$2.5Bn/a
Price to earnings211.827.9
Market value$36.5B$6.7B
Dividend yieldn/a0.43%
Rank by revenue in sector#38 of 523 · Health care#95 of 523 · Health care

Over the years

Revenue
BTSGU FY2022: $7.7BBTSGU FY2024: $7.7BBTSGU FY2024: $10.1BBTSGU FY2025: $12.9BCHE FY2018: $1.8BCHE FY2019: $1.9BCHE FY2020: $2.1BCHE FY2021: $2.1BCHE FY2022: $2.1BCHE FY2023: $2.3BCHE FY2024: $2.4BCHE FY2025: $2.5BFY18FY19FY20FY21FY22FY23FY24FY25
BTSGU $12.9BCHE $2.5B
Net income
BTSGU FY2022: -$53.9MBTSGU FY2024: -$154.6MBTSGU FY2024: -$18.1MBTSGU FY2025: $190.7MCHE FY2018: $205.5MCHE FY2019: $219.9MCHE FY2020: $319.5MCHE FY2021: $268.6MCHE FY2022: $249.6MCHE FY2023: $272.5MCHE FY2024: $302MCHE FY2025: $265.2MFY18FY19FY20FY21FY22FY23FY24FY25
BTSGU $190.7MCHE $265.2M
Net margin
BTSGU FY2022: -0.7%BTSGU FY2024: -2.0%BTSGU FY2024: -0.2%BTSGU FY2025: 1.5%CHE FY2018: 11.5%CHE FY2019: 11.3%CHE FY2020: 15.4%CHE FY2021: 12.6%CHE FY2022: 11.7%CHE FY2023: 12.0%CHE FY2024: 12.4%CHE FY2025: 10.5%FY18FY19FY20FY21FY22FY23FY24FY25
BTSGU 1.5%CHE 10.5%
Revenue growth
BTSGU FY2024: -0.4%BTSGU FY2024: +31.0%BTSGU FY2025: +28.2%CHE FY2019: +8.7%CHE FY2020: +7.3%CHE FY2021: +2.9%CHE FY2022: -0.2%CHE FY2023: +6.1%CHE FY2024: +7.4%CHE FY2025: +4.1%FY19FY20FY21FY22FY23FY24FY25
BTSGU +28.2%CHE +4.1%
Free cash flow
BTSGU FY2022: -$74.8MBTSGU FY2024: $137.3MBTSGU FY2024: -$57.1MBTSGU FY2025: $394.7MCHE FY2018: $234.3MCHE FY2019: $248.2MCHE FY2020: $430.5MCHE FY2021: $249.9MCHE FY2022: $252.6MCHE FY2023: $273.4MCHE FY2024: $368MCHE FY2025: $325.5MFY18FY19FY20FY21FY22FY23FY24FY25
BTSGU $394.7MCHE $325.5M

Fiscal years as each company reports them; the two may end in different months.

Questions about BrightSpring Health Services and Chemed

Which is bigger by revenue, BrightSpring Health Services or Chemed?

BrightSpring Health Services is bigger by revenue: $12.9B in fiscal 2025, against $2.5B for Chemed in fiscal 2025.

Which keeps more of its revenue as profit, BrightSpring Health Services or Chemed?

BrightSpring Health Services had a net margin of 1.5% in fiscal 2025; Chemed had 10.5% in fiscal 2025.

Which grew revenue faster, BrightSpring Health Services or Chemed?

In their latest fiscal years revenue changed by +28.2% at BrightSpring Health Services and +4.1% at Chemed.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies